The Government Accounting Office reviews drug spending for DOD, Medicare and Medicaid; finding that Medicaid generally paid the lowest prices, in some cases substantially lower.
Read More
The IMS Institute for Healthcare Informatics issued a report on cancer care facts and trends.
Read More
SureScripts routed over a billion prescriptions last year, 58% of the total. Outstanding progress has been made in moving to eprescribing.
http://surescripts.com/news-center/press-releases/!content/surescripts-reports-more-than-half-of-all-prescriptions-routed-electronically-in-2013-driving-adoption-of-broader-health-information-exchangeMagellan Rx Management has issued its fourth annual Medical Pharmacy Trend Report, which focuses on drugs paid under the medical benefit side of a health plan and finds continuing double-digit growth and the spread of various management techniques.
http://ir.magellanhealth.com/releasedetail.cfm?ReleaseID=846118The IMS Institute for Healthcare Informatics releases a report on health care spending and its relation to prescription drug use, finding an acceleration in the growth rate.
Read More
Catamaran, a large PBM, has issued its version of drug trend reporting, showing a per member per month trend of 2.4% in 2013 versus 2.6% in 2012. Upward pressure is almost all from brand drug unit price increases and greater use and cost of specialty drugs, offset by continued generic expansion. Catamaran is anticipating that trend could be as high as 5% in 2014, 6% in 2015 and 7.7% in 2016, driven by rising specialty use.
http://www.catamaranrx.com/uploadedFiles/Documents/Trend_Report/2014-Informed-Trends.pdfA study conducted in Canada and published in the Annals of Internal Medicine finds that as many as 31% of all written prescriptions are never filled, with cost, type of drug, age of the patient and regularity of visits to the same physician appearing to be associated with the rate of abandonment.
http://annals.org/article.aspx?articleid=1852865&utm_source=H2RMinutes+PCMH-ACO+Apr.+15%2C+2014&utm_campaign=PCMH-ACO+mins+4%2F15%2F14&utm_medium=emailExpress Scripts' 2013 Drug Trend Report provides the usual insight on medication utilization and cost from one of the countries largest pharmacy benefit managers.
Read More
A brief from the Employee Benefits Research Institute examines use of prescription drugs by enrollees in a high-deductible insurance plan, finding a greater percentage of generic prescriptions but in the…
Read More
According to Mark Farrah Associates, growth in Medicare Prescription Drug Plans slowed for the current year, with a little under one million net new members. Of the roughly 52 million Medicare beneficiaries, about 39 million have Part D coverage either through a stand-alone PDP or Medicare Advantage coverage. UnitedHealth, CVS Caremark and Humana are the largest players.
http://www.markfarrah.com/healthcare-business-strategy/The annual Pharmacy Benefit Management Institute Specialty Drug Benefit Report highlights trends in this growing category of drugs.
Read More
The FDA is going to re-examine how it regulates over the counter drugs, due to increasing safety concerns and the long passage of time since the rules were promulgated. Gee, next Congress might even decide to look at supplement regulation.
http://www.reuters.com/article/2014/02/21/us-usa-drugs-otc-idUSBREA1K1EW20140221A recent study in Health Affairs indicates that value-based insurance designs, at least in regard to drugs, may improve adherence but not save money.
Read More